Antiplatelet therapy [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

====== Antiplatelet therapy ======

===== Rationale for Antiplatelet Therapy =====

[[Endovascular treatment]]s involve the placement of foreign materials [[(coil]]s, [[stent]]s, or [[flow diverter]]s) that can trigger platelet aggregation and [[thrombus]] formation. [[Antiplatelet therapy]] mitigates this risk by inhibiting platelet activation and aggregation.

[[Dual Antiplatelet Therapy]] (DAPT): Standard regimen for stent-assisted coiling and flow diverter placement.

[[Single Antiplatelet Therapy]] (SAPT): Occasionally used for simple coiling procedures.

The use of [[antiplatelet]] [[therapy]] (including [[ASA]], [[aspirin]]) for [[stroke]] prevention in AF is increasingly limited:

Although antiplatelet agents reduce the risk of stroke in patients with AF, they are less effective than anticoagulant therapy.

In the AVERROES study, apixaban was superior to ASA for stroke prevention and was associated with a similar rate of major bleeding

===== Antiplatelet Therapy in Flow Diversion =====
[[Antiplatelet Therapy in Flow Diversion]]

===== Antiplatelet drug =====

[[Antiplatelet drug]].

===== Antiplatelet Therapy in Endovascular Treatment =====
[[Antiplatelet Therapy in Endovascular Treatment]]